Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Duffy

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Analytical Biochemistry|March 24, 2022
Implementation and continued validation of the malaria Plasmodium falciparum lactate dehydrogenase-based colorimetric assay for use in antiplasmodial drug screeningPatrick Valere Tsouh Fokou, Brice Mariscal Tchatat Tali, Darline Dize, et al.
Drug Discovery Today|January 20, 2024
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programsHerman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of <i>Trypanosoma brucei brucei</i>Darline Dize, Rolland Bantar Tata, Rodrigue Keumoe, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial ActivityNicolas Bosc, Eloy Felix, J Mark F Gardner, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Cheminformatics|February 23, 2021
MAIP: a web service for predicting blood-stage malaria inhibitorsNicolas Bosc, Eloy Felix, Ricardo Arcila, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 25, 2022
Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-outKoen J Dechering, Martijn Timmerman, Kim Rensen, et al.
Emergency Medicine Journal : EMJ|April 27, 2022
Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromesHimawan Fernando, Ziad Nehme, Diem Dinh, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria ChemoprotectionAnil K Gupta, Anders M Eliasen, Wil Andahazy, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemopreventionAnil K Gupta, James Pedroarena, Armen Nazarian, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Analytical Biochemistry|March 24, 2022
Implementation and continued validation of the malaria Plasmodium falciparum lactate dehydrogenase-based colorimetric assay for use in antiplasmodial drug screeningPatrick Valere Tsouh Fokou, Brice Mariscal Tchatat Tali, Darline Dize, et al.
Drug Discovery Today|January 20, 2024
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programsHerman van Vlijmen, Andrew D Pannifer, Phil Cochrane, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of <i>Trypanosoma brucei brucei</i>Darline Dize, Rolland Bantar Tata, Rodrigue Keumoe, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial ActivityNicolas Bosc, Eloy Felix, J Mark F Gardner, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Cheminformatics|February 23, 2021
MAIP: a web service for predicting blood-stage malaria inhibitorsNicolas Bosc, Eloy Felix, Ricardo Arcila, et al.
SLAS Discovery : Advancing Life Sciences R & D|July 25, 2022
Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-outKoen J Dechering, Martijn Timmerman, Kim Rensen, et al.
Emergency Medicine Journal : EMJ|April 27, 2022
Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromesHimawan Fernando, Ziad Nehme, Diem Dinh, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria ChemoprotectionAnil K Gupta, Anders M Eliasen, Wil Andahazy, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemopreventionAnil K Gupta, James Pedroarena, Armen Nazarian, et al.
Pageof 7